"10.1371_journal.pone.0136627","plos one","2015-08-25T00:00:00Z","Ting-Ting Chang; Tao-Cheng Wu; Po-Hsun Huang; Chih-Pei Lin; Jia-Shiong Chen; Liang-Yu Lin; Shing-Jong Lin; Jaw-Wen Chen","Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, R.O.C; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan, R.O.C; Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C; Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C","Conceived and designed the experiments: TTC TCW PHH CPL JSC LYL SJL JWC. Performed the experiments: TTC TCW PHH CPL JSC LYL. Analyzed the data: TTC TCW JSC LYL JWC. Contributed reagents/materials/analysis tools: TTC TCW PHH CPL JSC LYL SJL JWC. Wrote the paper: TTC TCW JWC.","In this study, aliskiren and olmesartan were given as gifts from Novartis and Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","08","Ting-Ting Chang","TTC",8,TRUE,8,6,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
